SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 156 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,253,172 | -23.0% | 10,338 | -27.0% | 0.00% | 0.0% |
Q2 2023 | $1,626,510 | -11.5% | 14,155 | +6.1% | 0.00% | -50.0% |
Q1 2023 | $1,838,238 | +3.7% | 13,337 | -36.4% | 0.00% | +100.0% |
Q4 2022 | $1,772,705 | +13.4% | 20,978 | +48.3% | 0.00% | -50.0% |
Q3 2022 | $1,563,000 | +39.8% | 14,144 | -42.9% | 0.00% | +100.0% |
Q2 2022 | $1,118,000 | -5.3% | 24,792 | +0.6% | 0.00% | 0.0% |
Q1 2022 | $1,180,000 | -20.6% | 24,638 | -28.8% | 0.00% | 0.0% |
Q4 2021 | $1,487,000 | +3.9% | 34,616 | -45.4% | 0.00% | -50.0% |
Q3 2021 | $1,431,000 | +85.4% | 63,441 | +138.7% | 0.00% | +100.0% |
Q2 2021 | $772,000 | -4.8% | 26,573 | -1.4% | 0.00% | 0.0% |
Q1 2021 | $811,000 | -90.7% | 26,956 | -66.7% | 0.00% | -90.0% |
Q4 2020 | $8,697,000 | +55.4% | 80,882 | +3.1% | 0.01% | +42.9% |
Q3 2020 | $5,597,000 | -0.4% | 78,444 | -14.3% | 0.01% | 0.0% |
Q2 2020 | $5,620,000 | +89.8% | 91,568 | +1.7% | 0.01% | +40.0% |
Q1 2020 | $2,961,000 | -37.4% | 90,018 | -5.4% | 0.01% | 0.0% |
Q4 2019 | $4,733,000 | +103.6% | 95,153 | +6.2% | 0.01% | +66.7% |
Q3 2019 | $2,325,000 | -52.9% | 89,583 | +1.0% | 0.00% | -57.1% |
Q2 2019 | $4,938,000 | +135.4% | 88,733 | +404.0% | 0.01% | +133.3% |
Q1 2019 | $2,098,000 | +20.6% | 17,605 | +10.5% | 0.00% | 0.0% |
Q4 2018 | $1,739,000 | -53.7% | 15,938 | -31.4% | 0.00% | -50.0% |
Q3 2018 | $3,753,000 | +77.7% | 23,234 | +45.4% | 0.01% | +50.0% |
Q2 2018 | $2,112,000 | +17.3% | 15,976 | -34.3% | 0.00% | +33.3% |
Q1 2018 | $1,801,000 | +32.9% | 24,310 | -0.2% | 0.00% | +50.0% |
Q4 2017 | $1,355,000 | +20.0% | 24,353 | -2.1% | 0.00% | 0.0% |
Q3 2017 | $1,129,000 | +218.0% | 24,881 | +136.1% | 0.00% | +100.0% |
Q2 2017 | $355,000 | +63.6% | 10,540 | +44.0% | 0.00% | 0.0% |
Q1 2017 | $217,000 | -22.2% | 7,318 | -28.1% | 0.00% | 0.0% |
Q4 2016 | $279,000 | -78.8% | 10,179 | -52.5% | 0.00% | -75.0% |
Q3 2016 | $1,316,000 | +355.4% | 21,423 | +41.4% | 0.00% | +300.0% |
Q2 2016 | $289,000 | +15.1% | 15,151 | +17.9% | 0.00% | 0.0% |
Q1 2016 | $251,000 | -46.1% | 12,851 | +6.3% | 0.00% | -50.0% |
Q4 2015 | $466,000 | +25.9% | 12,086 | +4.8% | 0.00% | 0.0% |
Q3 2015 | $370,000 | +15.6% | 11,536 | +9.5% | 0.00% | +100.0% |
Q2 2015 | $320,000 | +32.2% | 10,532 | -36.9% | 0.00% | 0.0% |
Q4 2014 | $242,000 | -14.5% | 16,697 | +24.4% | 0.00% | -50.0% |
Q3 2014 | $283,000 | -29.2% | 13,422 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $400,000 | +66.0% | 13,422 | +33.8% | 0.00% | 0.0% |
Q1 2014 | $241,000 | -84.9% | 10,028 | -70.4% | 0.00% | -85.7% |
Q3 2013 | $1,597,000 | -30.0% | 33,822 | -43.6% | 0.01% | -36.4% |
Q2 2013 | $2,281,000 | – | 59,961 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |